PARAPROTEINEMIAS

Clinical trials for PARAPROTEINEMIAS explained in plain language.

Never miss a new study

Get alerted when new PARAPROTEINEMIAS trials appear

Sign up with your email to follow new studies for PARAPROTEINEMIAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

One-Shot gene therapy trial offers hope for Hard-to-Treat blood cancer

Disease control Recruiting now

This early-stage trial is testing the safety of a new gene therapy called KLN-1010 for people with multiple myeloma that has returned after multiple treatments. The therapy aims to reprogram the patient's own immune cells inside their body to attack cancer cells. Researchers will…

Matched conditions: PARAPROTEINEMIAS

Phase: PHASE1 • Sponsor: Kelonia Therapeutics, Inc. • Aim: Disease control

Last updated Mar 13, 2026 15:05 UTC

PARAPROTEINEMIAS

Get alerted when new PARAPROTEINEMIAS trials appear

One-Shot gene therapy trial offers hope for Hard-to-Treat blood cancer